The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala event on June 7, 2018 at the Fairmont Grand Del Mar.
Tim has been placed on an exclusive shortlist of San Diego-based CEOs who show exceptional leadership in their work and hold admiration from their respective teams.
Novasyte is excited to announce that Tim Gleeson, Chairman and CEO, has been selected as a semi-finalist in the Ernst & Young Entrepreneur Of The Year 2018 San Diego Regional Awards program.
Novasyte is thrilled to announce the appointment of Todd Schaefer to Senior Vice President of Sales and Marketing. Todd officially joined Novasyte on Monday, April 9, 2018 and is the first to hold this position.
He will be responsible for managing the sales, marketing, pharma and recall departments within Novasyte. Additionally, he will be a part of Senior Leadership Team and will contribute to the development and execution of Novasyte’s strategic goals.
Novasyte has announced the creation and appointment of two corporate positions. Ryan Jones, formerly VP of Sales, now holds the title of VP of Pharma Services and Hillary Medina, formerly Senior Director of Recall Services, now acts as VP of Field and Recall Services. Both positions were effective on Monday, April 9, 2018.
There has been a historical trend in the med-tech industry for organizations to explore avenues to hire temporary staff (specifically their clinical teams) under the 1099 model, leading to misclassification of employees as independent contractors.
Despite this serving as a potential entry-point into the established medical device or diagnostic markets, it is evident that misclassifying workers as independent contractors is a bad idea for business. This problem is often motivated by organizations attempting to keep costs down while unknowingly adopting an unnecessary amount of risk and liability.
This risk and liability extends beyond the walls of their organization to their partner organizations. It's important to have visibility into and assess the potential risk and liability when hiring 1099 clinical teams or when initiating a new partnership with one of these employers. With the U.S. Department of Labor more strictly enforcing the classification of employees, med-tech companies must critically evaluate the risks they are exposed to should charges be filed, an accident happen on-site, or if there's a violation of overtime laws, among other independent contractor risks.